PVLA
Palvella TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
PVLA vs peer average
55/100
PVLA vs. peer average (C vs. C)
Grade spread
B 3 · C 1 · D 6
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
URGN is the first available peer comparator.
Useful specialty-biopharma comparator for a small company moving from development toward a focused commercial launch, though disease area overlap is limited.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PVLA
Palvella Therapeutics
URGN
UroGen
Grade
C
D
Momentum
89
96
Value
41
41
Sentiment
36
8
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs URGN
PVLA / URGN
Grade Position
In line
PVLA vs. peer average (C vs. C)
55/100
Momentum
89
URGNValue
41
PVLASentiment
36
PVLARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs PVLA
URGN is the first peer returned for this comparison set.